Regeneron Pharmaceuticals INC

Federal contracting record: $6.6B obligated across 12 awards from 3 agencies, FY 2016–2026.

$6.6B

Total Obligated

Award Records

Agencies Served

NAICS Codes

OverviewContracts Agencies NAICS

Company Profile

UEI (Unique Entity Identifier)

N3F9MH7E6HD6

CAGE Code

544P9

Parent Organization

Regeneron Pharmaceuticals INC

Address

777 OLD SAW MILL RIVER RD, TARRYTOWN, NY, 105916717

First Federal Award

Oct 21, 2015

Most Recent Award

Mar 26, 2026

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

Department of Defense
1 awards · 84.8% of total
$5.6B
Department of Health and Human Services
4 awards · 15.2% of total
$997M
Department of Veterans Affairs
7 awards · 0.0% of total
$642K

Top NAICS Activity

325414
BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
1 awards
$5.6B
541711
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
4 awards
$997M
325412
PHARMACEUTICAL PREPARATION MANUFACTURING
7 awards
$642K

Recent Federal Awards

Date	Agency	NAICS	Description	Amount
Aug 21, 2023	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD	$326M
Nov 24, 2021	Department of Veterans Affairs241-NETWORK CONTRACT OFFICE 01 (36C241)	325412	EVKEEZA DRUG	$494K
Sep 14, 2021	Department of DefenseW6QK ACC-APG NATICK	325414	PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC.	$2.9B
Sep 8, 2021	Department of Veterans Affairs241-NETWORK CONTRACT OFFICE 01 (36C241)	325412	EVKEEZA	$148K
Jan 12, 2021	Department of DefenseW6QK ACC-PICA	325414	PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC.	$2.6B
Jul 25, 2020	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF	$345M
Jun 18, 2020	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD	$54M
Jun 15, 2020	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD	$85M
Apr 29, 2020	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD	$9.2M
Apr 23, 2020	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF	$47M
Mar 21, 2020	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD	$93M
Jan 31, 2020	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD	$5.8M
Sep 25, 2019	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF	$23M
Sep 12, 2019	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD	$20M
May 22, 2019	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF	$132M
Aug 13, 2018	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF	$53M
May 9, 2018	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF	$26M
Feb 13, 2018	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF	$28M
Sep 28, 2017	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF	$40M
Sep 21, 2017	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD	$19M
May 31, 2017	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT IGF::OT::IGF	$15M
Nov 23, 2016	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF	$7.2M
Aug 12, 2016	Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA	541711	IGF::OT::IGF	$1.8M
Oct 21, 2015	Department of Health and Human ServicesOFF ASST SEC ADM AND MGMT	541711	REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT IGF::OT::IGF	$2.4M

Related Contractors

Other companies active in NAICS 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING.

Sanofi Vaccines US INC.

$1.2B

Advanced Technology International

$917M

Emergent Product Development Gaithersburg INC.

$276M

Seqirus USA INC

$104M

Seqirus INC

$56M

Valneva USA, INC.

$48M

Modernatx, INC.

$48M

Boehringer Ingelheim Animal Health France

$28M

Track Regeneron Pharmaceuticals INC Recompetes Before They Post

Mindy monitors Regeneron Pharmaceuticals INC's active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.

Get Free Recompete Alerts